Q2 Solutions Q2 Solutions Actionable Insights for Better Health and Lab Solutions
Press Release
| August 22, 2018

Q2 Solutions | EA Genomics receives New York State Clinical Laboratory Certification

Morrisville, NC - August 22, 2018 – Q2 Solutions | EA Genomics is proud to announce that it has received a Clinical Laboratory Certification from the New York State Department of Health in the category of oncology testing for molecular and cellular tumor markers. With this certification, our Comprehensive Cancer Panel (QCCP) next generation sequencing-based test for FFPE/fresh/frozen tissue specimens has been approved for clinical testing on patient specimens originating from New York state. This addition to the lab’s existing CLIA certification and CAP accreditation demonstrates our proven expertise with laboratory regulations and enables the lab to process specimens received from all 50 USA states, expanding opportunities for enrollment in clinical trials.

“This accomplishment opens many new opportunities for us in relation to trials requiring prospective genomic testing globally. In addition, achieving New York State certification clearly demonstrates our focus on high quality and regulatory compliant delivery”, said Kellie Yarnell, VP, Genomic Laboratories at Q2 Solutions.

The Q2 Solutions Comprehensive Cancer Panel is a targeted sequencing assay for analysis of genomic alterations predictive of response to therapies in clinical development. This 222-gene cancer panel includes the genes associated with multiple common cancers and can be used to assess various types of alterations including base substitutions, deletions, and insertions.

About Q2 Solutions
Q2 Solutions’ industry-leading genomic and bioinformatics services provide customers with DNA and RNA sequencing and other testing as well as the ability to mine data for invaluable insights for drug discovery, precision medicine and clinical development. Q2 Solutions | EA Genomics works with clients, using a wide array of technology platforms, to ensure maximum efficiency and quality delivery for every study. A joint venture of IQVIA (formerly QuintilesIMS) and Quest Diagnostics, Q2 Solutions combines the best of each parent organization’s clinical trials laboratory services capabilities to fulfill its mission of treating each sample as if a life depends on it. To learn more, visit www.q2labsolutions.com.